Milestone Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Milestone Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Milestone Pharmaceuticals Inc
Rating: 1.50125
Author: Trendlyne DVM scores

about

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be admi...

1.95 -0.04 (-2.01%)

36.27% Fall from 52W High

1.4M

XNAS Volume

XNAS 23 Jan, 2026 1:46 PM (EST)

Not Eligible

Expensive Valuation

3.5 / 100

Technically Neutral

56.6 / 100

No estimates available

Milestone Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Milestone Pharma Inc Live Stock Price Today, Share Analysis and Chart

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be admi...

36.27% Fall from 52W High

SWOT Analysis

Milestone Pharma Inc Live Price Chart